OBJECTIVE: To study the effects of dexmedetomidine (Dex) on cellular immunity during the perioperative period in children with brain neoplasms. METHODS:Forty children with brain neoplasms scheduled for selective operation were recruited and divided randomly into two groups. The Dex group was given a loading dose of 1 μg*kg(-1) Dex 15 minutes before anesthesia induction followed by a continuous infusion of 0.5 μg × kg(-1) × h(-1) Dex. Patients in control group received a same volume of normal saline for a same time period. Venous blood was collected before anesthesia (T0), 1 h after operation started (T1), immediately after operation ended (T2), 1 day after operation (T3) and 3 days after operation (T4), respectively. RESULTS:CD3 (+), CD4 (+), CD4 (+)/CD8 (+), NK and B cells at T1-T3 decreased significantly (P < 0.05) in both groups compared with those at T0, while the decrease of CD3 (+), CD4 (+), CD4 (+)/CD8 (+) and NK cells at T1-T3 and B cells at T1-T2 in Dex group was significantly less than the control group (P < 0.05). All values at T4 recovered to the level before anesthesia in both groups. CONCLUSION:Dex given by a continuous intravenous infusion during general anesthesia may effectively inhibit the stress responses and reduce the inhibition of cellular immunity in children with brain neoplasms during the perioperative period.
RCT Entities:
OBJECTIVE: To study the effects of dexmedetomidine (Dex) on cellular immunity during the perioperative period in children with brain neoplasms. METHODS: Forty children with brain neoplasms scheduled for selective operation were recruited and divided randomly into two groups. The Dex group was given a loading dose of 1 μg*kg(-1) Dex 15 minutes before anesthesia induction followed by a continuous infusion of 0.5 μg × kg(-1) × h(-1) Dex. Patients in control group received a same volume of normal saline for a same time period. Venous blood was collected before anesthesia (T0), 1 h after operation started (T1), immediately after operation ended (T2), 1 day after operation (T3) and 3 days after operation (T4), respectively. RESULTS: CD3 (+), CD4 (+), CD4 (+)/CD8 (+), NK and B cells at T1-T3 decreased significantly (P < 0.05) in both groups compared with those at T0, while the decrease of CD3 (+), CD4 (+), CD4 (+)/CD8 (+) and NK cells at T1-T3 and B cells at T1-T2 in Dex group was significantly less than the control group (P < 0.05). All values at T4 recovered to the level before anesthesia in both groups. CONCLUSION:Dex given by a continuous intravenous infusion during general anesthesia may effectively inhibit the stress responses and reduce the inhibition of cellular immunity in children with brain neoplasms during the perioperative period.
Entities:
Keywords:
B lymphocyte; Dexmedetomidine; NK cells; T lymphocyte; brain neoplasms
Authors: P Talke; R Chen; B Thomas; A Aggarwall; A Gottlieb; P Thorborg; S Heard; A Cheung; S L Son; A Kallio Journal: Anesth Analg Date: 2000-04 Impact factor: 5.108
Authors: Constantinos Chrysostomou; Lee Beerman; Dana Shiderly; Donald Berry; Victor O Morell; Ricardo Munoz Journal: Anesth Analg Date: 2008-11 Impact factor: 5.108
Authors: Erik H J G Aarntzen; I Jolanda M De Vries; W Joost Lesterhuis; Danita Schuurhuis; Joannes F M Jacobs; Kalijn Bol; Gerty Schreibelt; Roel Mus; Johannes H W De Wilt; John B A G Haanen; Dirk Schadendorf; Alexandra Croockewit; Willeke A M Blokx; Michelle M Van Rossum; William W Kwok; Gosse J Adema; Cornelis J A Punt; Carl G Figdor Journal: Cancer Res Date: 2012-10-18 Impact factor: 12.701
Authors: K A Boost; M Flondor; C Hofstetter; I Platacis; K Stegewerth; S Hoegl; T Nguyen; H Muhl; B Zwissler Journal: Acta Anaesthesiol Scand Date: 2007-08 Impact factor: 2.105